Year 2009 1. Poster Presentation Title: "Dietary Supplementation with Probiotic Formulation (Kibow Biotics®) on CKD III and IV patients – a Short Term Pilot Scale Study in Canada" presented at ASN 2009 (Oct. 27 to Nov. 1) in San Diego, CA View Abstract 2. An Editorial: "Can the bowel substitute for the kidney in advanced renal failure? - Current Medical Research and Opinion, Vol.25, No.8, 2009, 1913-1918 View Abstract 3. Brief Article: "Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada." Current Medical Research and Opinion, Vol.25, No.8, 2009, 1919-1930 View Abstract 4. Poster presentation title: Probiotics for Kidney health – Gut Based Uremic Toxin Removal – “Enteric Dialysis™” – Natarajan Ranganathan, Ph.D., and Eli A Friedman, MD at the 5th Asian Conference on Lactic Acid Bacteria Microbes in Disease Prevention, held July 1-3, 2009, Singapore. View Abstract 5. Enteric Dialysis™ - Brief introduction and its potential for CKD applications - Dr. N. Ranganathan – presented as an invited speaker at symposium 7 – Renal patient, at the Parenteral & Enteric Nutrition Society of Malaysia (PENSA) held June 5 – 7, 2009, Kuala Lumpur, Malaysia. View Abstract 6. Enteric Dialysis™ - Brief introduction and its potential for CKD applications - Dr. N. Ranganathan – invited speaker at the XXIX annual conference, Indian Society of Nephrology held Feb 6 – 8, 2009, Kanyakumari, India. View Abstract   Year 2008 1. Development of Room Temperature Stable Probiotics for CKD Applications - Presented at ASN 2008 View Abstract 2. Pilot Scale Human Clinical Trials with a Scientifically Validated Probiotic Formulation - Kibow Biotics® - With CKD Stage III and IV Patients (Mid-term and partial data analysis from Canada) - Presented at IDDST 2008 View Abstract 3. Oral ingestion of probiotics and fecal analysis in CKD III and IV patients - Preliminary observations - Presented at CPRD 2008 View Abstract   Year 2007 1. Pilot Clinical Trial of Probiotic Bacteria (Kibow Biotics®) in Chronic Kidney Disease (CKD) View Abstract 2. Progress in devising a bowel based probiotic therapy for uremia View Abstract   Year 2006 1. Progress in devising a bowel based probiotic therapy for uremia View Abstract 2. In Vitro and In Vivo Assessment of Intraintestinal Bacteriotherapy in Chronic Kidney Disease View Abstract 3. Effect of feeding Kibow Biotics® to cats and dogs in kidney failure View Abstract 4. Preliminary clinical evaluation of Kibow Biotics®, a probiotic agent, on feline azotemia View Abstract   Year 2005 1. Are Clinical Trials Warranted for a Dietary Supplement with Probiotics? View Abstract 2. Initial Safety Studies of a Probiotic for Renal Insufficiency View Abstract 3. Probiotics reduces Azotemia in Gottingen Minipigs View Abstract 4. Probiotic Amelioration of Azotemia in 5/6th Nephrectomized Sprague-Dawley Rats View Abstract 5. Short term effect of temperature on Kibow Biotics® View Abstract 6. Evaluation of Commercial Probiotic Products for Azotemia View Abstract   Year 2004 1. An introduction to Probiotics and its potential in Clinical applications View Abstract 2. Comparative microbial viability analysis in two delivery formats-Gel caps or mixed with food/diet View Abstract 3. Gut-Based Uremia Therapy : In vitro R&D Investigations of an Oral Probiotic Microbial Formulation with the Aid of a Simulated Human Intestinal Microbial Ecosystem (SHIME) Biochemical Reactor View Abstract 4. Gut-Based Uremia Therapy : Oral Bacteriotherapy Effectively Reduces Severity of Azotemia in 5/6th Nephrectomized Mini Pigs View Abstract 5. Gut based uremia therapy: Continued in vitro and in vivo R&D investigations on the application of oral probiotic bacteriotherapy towards Chronic Kidney Disease (CKD) patients View Abstract 6. Significance of dosage for effective clinical application of probiotics View Abstract 7. Mode of Delivery and Dosage are important factors for Uremia Therapy with Probiotics View Abstract 8. Probiotic Formulation in vitro effect on Phenol and p-Cresol levels View Abstract 9. Initial Trial of Probiotic Bacteria as Therapy for Uremia in Dogs View Abstract 10. Kibowbiotics is preferred and superior to yogurt for uremia applications View Abstract 11. Model of Chronic Renal Failure in Miniature Pigs View Abstract 12. Oral Probiotic treatment for Uremia in a Porcine Model of Chronic Renal Failure View Abstract 13. Substitution of the kidney function by the bowel in Azotemia View Abstract   Year 2003 1. Artificial Swallowable Kidney Formulation View Abstract 2. Oral Bacteriotherapy Effectively Reduces Severity of Azotemia in 5/6th Nephrectomized Rats View Abstract 3. Streptococcus thermophilus KB19 is a Potential component of a Probiotic Regimen Applicable in Enteric Dialysis for Uremia View Abstract 4. Rate of Urea Hydrolysis by Streptococcus thermophilus KB19 is comparable to Soil Bacterium Bacillus pasteurii and Genetically Engineered Urealytic E.coli View Abstract 5. Probiotics Extend Survival in Untreated 5/6 Nephrectomized Rats: Possible Use for Probiotics as An Adjunct in Chronic Renal Failure (CRF)® View Abstract   Year 2002 1. Probiotics to Eliminate Nitrogenous Metabolites View Abstract 2. A Novel Synbiotic for Augmenting Kidney Function View Abstract 3. Urea Hydrolysis and Ammonia Uptake by Bacillus pasteurii View Abstract 4. Urease Activity in Commercial Yogurt View Abstract 5. Bacillus pasteurii: A Small Microbe with Huge Potential View Abstract 6. A Nutraceutical Approach to Pre-Dialysis View Abstract 7. Viability of Probiotics in Gastric Juice and Artificial Intestinal Fluid View Abstract   Year 2001 1. Probiotics to Eliminate Nitrogenous Metabolites View Abstract